Join Dr Elizabeth Bancroft, Nurse Consultant in Oncogenetics Research at the Royal Marsden Hospital and Chief Nurse of the North Thames Genomic Medicine Service Alliance, for an engaging session on the evolving role of genetics in prostate cancer care. With over two decades of experience in cancer genetics, Dr Bancroft draws from her work leading the UK’s first nurse-led prostate cancer genetic risk clinic to deliver practical insights for clinical application.
In this webinar, Dr Bancroft will explore the distinctions between germline and somatic genetic alterations in prostate cancer and the implications of genetic testing for both patients and their families. She will highlight the integral role of genetic counselling, emerging trends in genomics, and address critical disparities in access to genetic services.
This session is a must-watch for healthcare professionals aiming to stay at the forefront of personalised medicine in prostate cancer care and those looking to integrate cutting-edge genetic knowledge into their everyday practice.
